Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

21.82
+0.56002.63%
Post-market: 22.090.2685+1.23%19:41 EDT
Volume:1.42M
Turnover:31.26M
Market Cap:4.24B
PE:-43.57
High:22.37
Open:21.44
Low:21.38
Close:21.26
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:90.19M
Volume Ratio:0.58
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.45
PE(LYR):-13.47

Loading ...

UBS Downgrades Legend Biotech to Neutral From Buy, Adjusts Price Target to $28 From $49

MT Newswires Live
·
Jul 24

Legend Biotech downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO)

TIPRANKS
·
Jul 16

Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution

TIPRANKS
·
Jul 15

Legend Biotech: Carvykti® Generated About $657 Million in Net Trade Sales During Qtr Ended June 30, 2026

THOMSON REUTERS
·
Jul 15

Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)

TIPRANKS
·
Jul 14

Legend Biotech Price Target Announced at $35.00/share by JP Morgan

Dow Jones
·
Jul 13

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Legend Biotech Insider Move: Director Offloads Stake in High-Profile Transaction

TIPRANKS
·
Jul 03

Legend Biotech Director Casey Patrick John Disposes of 6,000 Common Shares for $88,800

Reuters
·
Jul 03

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.d., to Board of Directors

THOMSON REUTERS
·
Jun 23

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

GlobeNewswire
·
Jun 23

Legend Biotech Prices $226 Million ADS Offering to Bolster Cell Therapy Expansion

TIPRANKS
·
Jun 23

Legend Biotech prices 7,700,000 ADS follow-on offering at $29.35 each

Reuters
·
Jun 23

Movement Alert|Legend Biotech Rises 5.44% in Regular Trading, $226 Million ADS Offering Completed Combined with Positive Lymphoma Therapy Data

Market Focus
·
Jun 23

3 US Growth Stocks With Strong Balance Sheets And Earnings Focus

Simply Wall St.
·
Jun 19

Legend Biotech (LEGN) Stock Could Be 51.2% Undervalued After Equity Raise And LB2501 Data

Simply Wall St.
·
Jun 19

Movement Alert|Legend Biotech Falls 16.02% in Regular Trading, Secondary Offering of $226 Million ADS Priced at Discount

Market Focus
·
Jun 19

BUZZ-U.S. STOCKS ON THE MOVE-Kardigan, Energy companies

Reuters
·
Jun 18